Gleason 7 (4+3) скачать в хорошем качестве

Gleason 7 (4+3)

PCRI's Alex and Medical Oncologist Mark Scholz, MD, give a survey of newly diagnosed Gleason 4+3=7 prostate cancer in light of the recent introduction of PSMA PET scans into the staging process. Dr. Scholz discusses staging, treatment options, and the new ambiguity of whether hormone therapy is as important for this stage of prostate cancer if a person has a negative PSMA PET scan. 0:07 Why does Gleason 4+3=7 (a.k.a Epstein grade group 3) prostate cancer require treatment in most cases? 2:01 If a Gleason 4+3=7 patient has a negative PSMA PET scan, what should his next steps be? 3:27 How do the size and location of the tumor(s) factor into treatment decisions? 5:16 How would a patient find an expert practitioner of focal therapy? 5:39 Which side effects should a patient anticipate if they are undergoing radiation? 6:31 What are the side effects of a focal procedure like HI-FU? 7:36 Does Tulsa-Pro cause any scarring or urinary issues? 8:02 What are the survival rates for men with Gleason 4+3 prostate cancer? 8:45 Does the presence of seminal vesicle invasion affect the treatment protocol? 9:46 Does seminal vesicle invasion require the addition of hormone therapy to the treatment protocol? 10:50 Should patients have PSMA PET scans after treatment? 11:32 Why have you not discussed surgery yet as a possible treatment for Gleason 4+3? Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org To learn more about prostate cancer visit http://www.pcri.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #ProstateCancer #MarkScholzMD #PCRI